Continuing the AGIX Liver Failure research - Very difficult to find 'typical' background rates associated with different drugs. But ACE Inhibitors (75% of ARISE patients on them) and Gylcemic Control drugs both seem to have occassional liver failures associated with them. But impossible to tell the rate since the trials are mostly not in the FDA database.
Market Data 
Markets 
AI
